subject area of
- 2017 Scientific Sessions Sol Sherry Distinguished Lecture in Thrombosis Journal Articles
- A Phase II randomized controlled trial evaluated antithrombotic treatment with fesomersen in patients with kidney failure on hemodialysis Journal Articles
- AB023, A Novel Antibody That Binds Factor XI and Blocks Its Activation by Factor XIIa Journal Articles
- Abelacimab for Prevention of Venous Thromboembolism Journal Articles
- Advances in Antithrombotic Therapy Journal Articles
- Allosteric modulation of exosite 1 attenuates polyphosphate-catalyzed activation of factor XI by thrombin Journal Articles
- Anticoagulation in patients with kidney failure on dialysis: factor XI as a therapeutic target Journal Articles
- Antithrombotic Agents Journal Articles
- Current Gaps in the Provision of Safe and Effective Anticoagulation in Atrial Fibrillation and the Potential for Factor XI-Directed Therapeutics Journal Articles
- Emerging anticoagulant strategies Journal Articles
- Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis Journal Articles
- Factor XI Antisense Oligonucleotide for Venous Thrombosis Journal Articles
- Factor XI Inhibitors: Potential Role in End-Stage Kidney Disease Journal Articles
- Factor XI and factor XII as targets for new anticoagulants Journal Articles
- Factor XI as a Target for New Anticoagulants Journal Articles
- Factor XI inhibition in cardiovascular disease Journal Articles
- Factor XI inhibitors: cardiovascular perspectives Journal Articles
- Factor XI inhibitors: what should clinicians know Journal Articles
- Factors XI and XII are low in subjects with liver disease Journal Articles
- Gene-Gene Interaction Between Factor- XI and ABO Genes in Cerebral Venous Thrombosis Journal Articles
- High prevalence of abnormal preoperative coagulation tests in patients with adolescent idiopathic scoliosis Journal Articles
- Histidine-rich glycoprotein binds factor XIIa with high affinity and inhibits contact-initiated coagulation Journal Articles
- Interactions of antithrombin and proteins in the plasma contact activation system with immobilized functional heparin Journal Articles
- MAA868 locks factor XIa in a zymogen-like state Journal Articles
- New Therapeutic Targets for the Prevention and Treatment of Venous Thromboembolism With a Focus on Factor XI Inhibitors Journal Articles
- New developments in anticoagulants: Past, present and future Journal Articles
- News at XI: moving beyond factor Xa inhibitors Journal Articles
- Novel Drug Targets for Ischemic Stroke Identified Through Mendelian Randomization Analysis of the Blood Proteome Journal Articles
- Selective depletion of factor XI or factor XII with antisense oligonucleotides attenuates catheter thrombosis in rabbits Journal Articles
- The contact activation inhibitor AB023 in heparin-free hemodialysis: results of a randomized phase 2 clinical trial Journal Articles
- Transfusion-Induced Specific Anti–Factor XI Inhibitor in a Patient with Previously Unrecognized Factor XI Deficiency Journal Articles
- Treatment of Cancer-Associated Thrombosis: Recent Advances, Unmet Needs, and Future Direction Journal Articles
- What Is the Future of Factor XI Inhibitors? Journal Articles